Kimia Farma Persero Tbk (KAEF) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Kimia Farma Persero Tbk (KAEF) has a cash flow conversion efficiency ratio of 0.033x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rp87.10 Billion ≈ $5.10 Million USD) by net assets (Rp2.63 Trillion ≈ $154.31 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See KAEF defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
Kimia Farma Persero Tbk - Cash Flow Conversion Efficiency Trend (2003–2025)
This chart illustrates how Kimia Farma Persero Tbk's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Kimia Farma Persero Tbk Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Kimia Farma Persero Tbk ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Soke Degirmencilik AS
IS:SOKE
|
0.071x |
|
Acusensus Ltd
AU:ACE
|
0.023x |
|
Kyungbangco.Ltd
KO:000050
|
0.017x |
|
Min Aik Technology Co Ltd
TW:3060
|
-0.038x |
|
AAPICO Hitech Public Company Limited
BK:AH
|
0.036x |
|
GeoVision Inc
TW:3356
|
-0.025x |
|
Compugen
TA:CGEN
|
0.099x |
|
SK D&D Co Ltd
KO:210980
|
-0.133x |
Annual Cash Flow Conversion Efficiency for Kimia Farma Persero Tbk (2003–2025)
The table below shows the annual cash flow conversion efficiency of Kimia Farma Persero Tbk from 2003 to 2025. For the full company profile with market capitalisation and key ratios, see KAEF stock market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | Rp2.51 Trillion ≈ $147.06 Million |
Rp236.75 Billion ≈ $13.87 Million |
0.094x | +110.55% |
| 2024-12-31 | Rp3.43 Trillion ≈ $200.91 Million |
Rp153.62 Billion ≈ $9.00 Million |
0.045x | +178.56% |
| 2023-12-31 | Rp6.39 Trillion ≈ $374.59 Million |
Rp-364.58 Billion ≈ $-21.36 Million |
-0.057x | -232.05% |
| 2022-12-31 | Rp9.34 Trillion ≈ $547.25 Million |
Rp403.34 Billion ≈ $23.63 Million |
0.043x | +239.48% |
| 2021-12-31 | Rp7.23 Trillion ≈ $423.76 Million |
Rp-223.92 Billion ≈ $-13.12 Million |
-0.031x | -121.59% |
| 2020-12-31 | Rp7.11 Trillion ≈ $416.36 Million |
Rp1.02 Trillion ≈ $59.71 Million |
0.143x | +157.34% |
| 2019-12-31 | Rp7.41 Trillion ≈ $434.37 Million |
Rp-1.85 Trillion ≈ $-108.63 Million |
-0.250x | -528.82% |
| 2018-12-31 | Rp3.36 Trillion ≈ $196.68 Million |
Rp195.75 Billion ≈ $11.47 Million |
0.058x | +359.68% |
| 2017-12-31 | Rp2.57 Trillion ≈ $150.74 Million |
Rp32.64 Billion ≈ $1.91 Million |
0.013x | -86.50% |
| 2016-12-31 | Rp2.27 Trillion ≈ $133.10 Million |
Rp213.43 Billion ≈ $12.51 Million |
0.094x | -13.74% |
| 2015-12-31 | Rp1.86 Trillion ≈ $109.11 Million |
Rp202.84 Billion ≈ $11.89 Million |
0.109x | -31.09% |
| 2014-12-31 | Rp1.81 Trillion ≈ $106.13 Million |
Rp286.31 Billion ≈ $16.78 Million |
0.158x | +1.18% |
| 2013-12-31 | Rp1.62 Trillion ≈ $95.18 Million |
Rp253.78 Billion ≈ $14.87 Million |
0.156x | -2.34% |
| 2012-12-31 | Rp1.44 Trillion ≈ $84.47 Million |
Rp230.61 Billion ≈ $13.51 Million |
0.160x | +138.80% |
| 2011-12-31 | Rp1.25 Trillion ≈ $73.39 Million |
Rp83.91 Billion ≈ $4.92 Million |
0.067x | -47.21% |
| 2010-12-31 | Rp1.11 Trillion ≈ $65.28 Million |
Rp141.37 Billion ≈ $8.28 Million |
0.127x | +3.52% |
| 2009-12-31 | Rp995.32 Billion ≈ $58.32 Million |
Rp122.01 Billion ≈ $7.15 Million |
0.123x | +504.90% |
| 2008-12-31 | Rp947.76 Billion ≈ $55.54 Million |
Rp-28.69 Billion ≈ $-1.68 Million |
-0.030x | -149.52% |
| 2007-12-31 | Rp908.03 Billion ≈ $53.21 Million |
Rp55.51 Billion ≈ $3.25 Million |
0.061x | -62.05% |
| 2006-12-31 | Rp870.65 Billion ≈ $51.02 Million |
Rp140.24 Billion ≈ $8.22 Million |
0.161x | +344.45% |
| 2005-12-31 | Rp844.22 Billion ≈ $49.47 Million |
Rp30.60 Billion ≈ $1.79 Million |
0.036x | -91.31% |
| 2003-12-31 | Rp754.46 Billion ≈ $44.21 Million |
Rp314.63 Billion ≈ $18.44 Million |
0.417x | -- |
About Kimia Farma Persero Tbk
PT Kimia Farma Tbk, together with its subsidiaries, researches, develops, manufactures, and sells pharmaceutical products in Indonesia and internationally. It offers generic drugs, ethical products, over-the-counter products, herbs, and cosmetic products. The company also provides integrated health clinic and medical laboratory services; operates a beauty clinic; and retails pharmaceutical produc… Read more